Published in Nat Rev Microbiol on December 04, 2006
A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell (2010) 11.20
Microbial seed banks: the ecological and evolutionary implications of dormancy. Nat Rev Microbiol (2011) 4.09
Metabolite-enabled eradication of bacterial persisters by aminoglycosides. Nature (2011) 4.06
Bistability and biofilm formation in Bacillus subtilis. Mol Microbiol (2007) 3.83
Platforms for antibiotic discovery. Nat Rev Drug Discov (2013) 3.66
Active starvation responses mediate antibiotic tolerance in biofilms and nutrient-limited bacteria. Science (2011) 3.66
Dormancy contributes to the maintenance of microbial diversity. Proc Natl Acad Sci U S A (2010) 3.33
Efflux-mediated drug resistance in bacteria: an update. Drugs (2009) 3.18
Ciprofloxacin causes persister formation by inducing the TisB toxin in Escherichia coli. PLoS Biol (2010) 3.12
Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy. Proc Natl Acad Sci U S A (2009) 3.01
Signaling-mediated bacterial persister formation. Nat Chem Biol (2012) 2.96
Artemisinin‐induced dormancy in plasmodium falciparum: duration, recovery rates, and implications in treatment failure. J Infect Dis (2010) 2.89
Assembly and development of the Pseudomonas aeruginosa biofilm matrix. PLoS Pathog (2009) 2.85
New concepts of resistance in the treatment of Helicobacter pylori infections. Nat Clin Pract Gastroenterol Hepatol (2008) 2.83
Molecular mechanisms of HipA-mediated multidrug tolerance and its neutralization by HipB. Science (2009) 2.74
Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections. Nat Rev Microbiol (2011) 2.68
Fundamentals of microbial community resistance and resilience. Front Microbiol (2012) 2.53
Novel approaches to developing new antibiotics for bacterial infections. Br J Pharmacol (2007) 2.43
Role of global regulators and nucleotide metabolism in antibiotic tolerance in Escherichia coli. Antimicrob Agents Chemother (2008) 2.40
Growth of Mycobacterium tuberculosis biofilms containing free mycolic acids and harbouring drug-tolerant bacteria. Mol Microbiol (2008) 2.35
SOS response induces persistence to fluoroquinolones in Escherichia coli. PLoS Genet (2009) 2.28
A novel mechanism of programmed cell death in bacteria by toxin-antitoxin systems corrupts peptidoglycan synthesis. PLoS Biol (2011) 2.27
Regulation of phenotypic variability by a threshold-based mechanism underlies bacterial persistence. Proc Natl Acad Sci U S A (2010) 2.20
Toxin-antitoxin systems influence biofilm and persister cell formation and the general stress response. Appl Environ Microbiol (2011) 2.19
Treatment and prevention of urinary tract infection with orally active FimH inhibitors. Sci Transl Med (2011) 2.16
Staphylococcus aureus phenotype switching: an effective bacterial strategy to escape host immune response and establish a chronic infection. EMBO Mol Med (2011) 2.15
Emergence of Pseudomonas aeruginosa strains producing high levels of persister cells in patients with cystic fibrosis. J Bacteriol (2010) 2.11
Siderophores from neighboring organisms promote the growth of uncultured bacteria. Chem Biol (2010) 2.04
Why is long-term therapy required to cure tuberculosis? PLoS Med (2007) 2.03
Persistence of Borrelia burgdorferi following antibiotic treatment in mice. Antimicrob Agents Chemother (2008) 2.02
A model of bacterial intestinal infections in Drosophila melanogaster. PLoS Pathog (2007) 2.02
Bacterial growth and cell division: a mycobacterial perspective. Microbiol Mol Biol Rev (2008) 2.01
Persistence of Borrelia burgdorferi in rhesus macaques following antibiotic treatment of disseminated infection. PLoS One (2012) 2.01
Single-cell protein induction dynamics reveals a period of vulnerability to antibiotics in persister bacteria. Proc Natl Acad Sci U S A (2008) 1.98
The systemic imprint of growth and its uses in ecological (meta)genomics. PLoS Genet (2010) 1.94
Asymmetry and aging of mycobacterial cells lead to variable growth and antibiotic susceptibility. Science (2011) 1.87
Functional roles of pulsing in genetic circuits. Science (2013) 1.84
Cecum lymph node dendritic cells harbor slow-growing bacteria phenotypically tolerant to antibiotic treatment. PLoS Biol (2014) 1.81
Antibiotic sensitivity profiles determined with an Escherichia coli gene knockout collection: generating an antibiotic bar code. Antimicrob Agents Chemother (2010) 1.78
Eradication of bacterial persisters with antibiotic-generated hydroxyl radicals. Proc Natl Acad Sci U S A (2012) 1.74
Microbiology of odontogenic bacteremia: beyond endocarditis. Clin Microbiol Rev (2009) 1.71
Factors contributing to the biofilm-deficient phenotype of Staphylococcus aureus sarA mutants. PLoS One (2008) 1.69
A new type V toxin-antitoxin system where mRNA for toxin GhoT is cleaved by antitoxin GhoS. Nat Chem Biol (2012) 1.67
Isolation and characterization of superdormant spores of Bacillus species. J Bacteriol (2009) 1.65
Metazoan operons accelerate recovery from growth-arrested states. Cell (2011) 1.64
Toxins Hha and CspD and small RNA regulator Hfq are involved in persister cell formation through MqsR in Escherichia coli. Biochem Biophys Res Commun (2009) 1.62
Enhanced Efflux Activity Facilitates Drug Tolerance in Dormant Bacterial Cells. Mol Cell (2016) 1.61
Interplay between gene expression noise and regulatory network architecture. Trends Genet (2012) 1.61
Increased antibiotic resistance of Escherichia coli in mature biofilms. Appl Environ Microbiol (2009) 1.60
Ineffectiveness of tigecycline against persistent Borrelia burgdorferi. Antimicrob Agents Chemother (2009) 1.60
Direct Correlation between Motile Behavior and Protein Abundance in Single Cells. PLoS Comput Biol (2016) 1.56
Gentamicin promotes Staphylococcus aureus biofilms on silk suture. J Surg Res (2011) 1.53
HipBA-promoter structures reveal the basis of heritable multidrug tolerance. Nature (2015) 1.53
'Division of labour' in response to host oxidative burst drives a fatal Cryptococcus gattii outbreak. Nat Commun (2014) 1.52
Dormancy is not necessary or sufficient for bacterial persistence. Antimicrob Agents Chemother (2013) 1.51
Microbial population and community dynamics on plant roots and their feedbacks on plant communities. Annu Rev Microbiol (2012) 1.50
Importance of prophages to evolution and virulence of bacterial pathogens. Virulence (2013) 1.48
Heterogeneous bacterial persisters and engineering approaches to eliminate them. Curr Opin Microbiol (2011) 1.47
Treatment algorithms for chronic osteomyelitis. Dtsch Arztebl Int (2012) 1.47
Patients with long-term oral carriage harbor high-persister mutants of Candida albicans. Antimicrob Agents Chemother (2009) 1.46
Dosing regimen matters: the importance of early intervention and rapid attainment of the pharmacokinetic/pharmacodynamic target. Antimicrob Agents Chemother (2012) 1.43
Effect of DNase and antibiotics on biofilm characteristics. Antimicrob Agents Chemother (2008) 1.42
Cell division in Escherichia coli cultures monitored at single cell resolution. BMC Microbiol (2008) 1.41
Histologic, Molecular, and Clinical Evaluation of Explanted Breast Prostheses, Capsules, and Acellular Dermal Matrices for Bacteria. Aesthet Surg J (2015) 1.40
Microtiter susceptibility testing of microbes growing on peg lids: a miniaturized biofilm model for high-throughput screening. Nat Protoc (2010) 1.36
Memory and modularity in cell-fate decision making. Nature (2013) 1.36
Pseudomonas aeruginosa increases formation of multidrug-tolerant persister cells in response to quorum-sensing signaling molecules. J Bacteriol (2010) 1.35
The molecular alarmone (p)ppGpp mediates stress responses, vancomycin tolerance, and virulence in Enterococcus faecalis. J Bacteriol (2009) 1.35
Exit from dormancy in microbial organisms. Nat Rev Microbiol (2010) 1.35
The innate growth bistability and fitness landscapes of antibiotic-resistant bacteria. Science (2013) 1.34
VapC-1 of nontypeable Haemophilus influenzae is a ribonuclease. J Bacteriol (2007) 1.33
Arrested protein synthesis increases persister-like cell formation. Antimicrob Agents Chemother (2013) 1.33
The chromosomal toxin gene yafQ is a determinant of multidrug tolerance for Escherichia coli growing in a biofilm. Antimicrob Agents Chemother (2009) 1.33
Oritavancin kills stationary-phase and biofilm Staphylococcus aureus cells in vitro. Antimicrob Agents Chemother (2008) 1.32
Generating aptamers for recognition of virus-infected cells. Clin Chem (2009) 1.31
Lessons learned and unlearned in periodontal microbiology. Periodontol 2000 (2013) 1.30
Bacterial persister cell formation and dormancy. Appl Environ Microbiol (2013) 1.28
Staphylococcus aureus persisters tolerant to bactericidal antibiotics. J Mol Microbiol Biotechnol (2012) 1.25
The Bps polysaccharide of Bordetella pertussis promotes colonization and biofilm formation in the nose by functioning as an adhesin. Mol Microbiol (2010) 1.25
Characterization of the interaction and cross-regulation of three Mycobacterium tuberculosis RelBE modules. PLoS One (2010) 1.22
Brominated furanones inhibit biofilm formation by Salmonella enterica serovar Typhimurium. Appl Environ Microbiol (2008) 1.22
The frequency of persisters in Escherichia coli reflects the kinetics of awakening from dormancy. J Bacteriol (2010) 1.22
Antibiotic resistance in Chlamydiae. Future Microbiol (2010) 1.22
Understanding microbial cooperation. J Theor Biol (2011) 1.21
The proteomics of quiescent and nonquiescent cell differentiation in yeast stationary-phase cultures. Mol Biol Cell (2011) 1.21
A novel role for enzyme I of the Vibrio cholerae phosphoenolpyruvate phosphotransferase system in regulation of growth in a biofilm. J Bacteriol (2007) 1.21
Increasing the duration of dual amoxicillin plus omeprazole Helicobacter pylori eradication to 6 weeks: a pilot study. J Gastroenterol Hepatol (2012) 1.20
Immune defence, parasite evasion strategies and their relevance for 'macroscopic phenomena' such as virulence. Philos Trans R Soc Lond B Biol Sci (2009) 1.20
Evolutionary determinants of cancer. Cancer Discov (2015) 1.19
"Persisters": survival at the cellular level. PLoS Pathog (2011) 1.19
Selective killing of bacterial persisters by a single chemical compound without affecting normal antibiotic-sensitive cells. Antimicrob Agents Chemother (2011) 1.19
Bacterial cheating drives the population dynamics of cooperative antibiotic resistance plasmids. Mol Syst Biol (2013) 1.19
Anti-infective activities of lactobacillus strains in the human intestinal microbiota: from probiotics to gastrointestinal anti-infectious biotherapeutic agents. Clin Microbiol Rev (2014) 1.17
Cationic antimicrobial polymers and their assemblies. Int J Mol Sci (2013) 1.16
Starvation, together with the SOS response, mediates high biofilm-specific tolerance to the fluoroquinolone ofloxacin. PLoS Genet (2013) 1.16
Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics. Microbiol Mol Biol Rev (2014) 1.16
Role of efflux pumps in the antibiotic resistance of bacteria embedded in a biofilm. Virulence (2013) 1.15
From in vitro to in vivo Models of Bacterial Biofilm-Related Infections. Pathogens (2013) 1.15
Cultivation of a Synergistetes strain representing a previously uncultivated lineage. Environ Microbiol (2010) 1.14
Is bacterial persistence a social trait? PLoS One (2007) 1.14